Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation

被引:81
|
作者
Garrison, Allison M. [1 ]
Parrott, Jennifer M. [1 ]
Tunon, Arnulfo [1 ]
Delgado, Jennifer [1 ]
Redus, Laney [1 ]
O'Connor, Jason C. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Ctr Biomed Neurosci, San Antonio, TX 78229 USA
[3] South Texas Vet Hlth Syst, Audie L Murphy VA Hosp, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
Inflammation; Cytokines; Kynurenine metabolism; Microglia; ARYL-HYDROCARBON RECEPTOR; QUINOLINIC ACID; ENDOGENOUS EXCITANT; REGIONAL-VARIATIONS; INHIBITION; BRAIN; 3-MONOOXYGENASE; MODEL; INFLAMMATION; TRYPTOPHAN;
D O I
10.1016/j.psyneuen.2018.04.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic stress or inflammation increases tryptophan metabolism along the kynurenine pathway (KP), and the generation of neuroactive kynurenine metabolites contributes to subsequent depressive-like behaviors. Microglia regulate KP balance by preferentially producing oxidative metabolites, including quinolinic acid. Research has focused on the interplay between cytokines and HPA axis-derived corticosteroids in regulating microglial activity and effects of KP metabolites directly on neurons; however, the potential role that KP metabolites have directly on microglial activity is unknown. Here, murine microglia were stimulated with lipopolysaccharide (LPS). After 6 h, mRNA expression of interleukin(IL)-1 beta, IL-6, tumor necrosis factor(TNF)-alpha and inducible nitric oxide synthase(iNOS) was dose-dependently increased along with the rate-limiting enzymes for oxidative KP metabolism, indoleamine-2,3-dioxygenase(IDO)-1 and kynurenine 3-monooxygenase(KMO). By 24 h post-LPS, kynurenine and quinolinic acid in the media was elevated. Inhibiting KMO with Ro 61-8048 during LPS challenge attenuated extracellular nitrite accumulation and expression of KMO and TNF-alpha in response to LPS. Similarly, primary microglia isolated from KMO-/- mice exhibited a significantly reduced pro-inflammatory response to LPS compared to WT controls. To determine whether the substrate (kynurenine) or end product (quinolinic add) of KMO-dependent metabolism modulates the LPS response, microglia were treated with increasing concentrations of L-kynurenine or quinolinic acid in combination with LPS or saline. Interestingly, quinolinic acid did not impact the microglial LPS response. However, L-kynurenine had dose-dependent inhibitory effect on the LPS response. These data are the first to show an anti-inflammatory effect of KMO inhibition on microglia during immune challenge and suggest that KP metabolic balance may play a direct role in regulating microglia activity.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
    Phillips, Robert S.
    Iradukunda, Emma Carine
    Hughes, Tamera
    Bowen, J. Phillip
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2019, 6
  • [2] The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
    Hughes, Tamera D.
    Guner, Osman F.
    Iradukunda, Emma Carine
    Phillips, Robert S.
    Bowen, J. Phillip
    MOLECULES, 2022, 27 (01):
  • [3] Involvement of the kynurenine pathway in neuroinflammation
    Guillemin, Gilles J.
    Cullen, Karen M.
    Smythe, George A.
    Brew, Bruce J.
    INFLAMMATION RESEARCH, 2005, 54 : S199 - S199
  • [4] Targeting the kynurenine pathway
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (11) : 816 - 816
  • [5] Modulating kynurenine monooxygenase in microglia: The need for further characterization
    Moon, P. K.
    Minhas, P. S.
    PSYCHONEUROENDOCRINOLOGY, 2018, 98 : 230 - 230
  • [6] The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
    Favennec, Marie
    Hennart, Benjamin
    Caiazzo, Robert
    Leloire, Audrey
    Yengo, Loic
    Verbanck, Marie
    Arredouani, Abdelilah
    Marre, Michel
    Pigeyre, Marie
    Bessede, Alban
    Guillemin, Gilles J.
    Chinetti, Giulia
    Staels, Bart
    Pattou, Francois
    Balkau, Beverley
    Allorge, Delphine
    Froguel, Philippe
    Poulain-Godefroy, Odile
    OBESITY, 2015, 23 (10) : 2066 - 2074
  • [7] IMPAIRED CORTICAL KYNURENINE PATHWAY METABOLISM IN SCHIZOPHRENIA: FOCUS ON KYNURENINE 3-MONOOXYGENASE
    Schwarcz, Robert
    Sathyasaikumar, K. V.
    Stachowski, E.
    Wonodi, I.
    Roberts, R. C.
    Thaker, G.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 149 - 149
  • [8] Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas
    Vazquez Cervantes, Gustavo Ignacio
    Pineda, Benjamin
    Ramirez Ortega, Daniela
    Salazar, Aleli
    Gonzalez Esquivel, Dinora Fabiola
    Rembao, Daniel
    Zavala Vega, Sergio
    Gomez-Manzo, Saul
    Perez de la Cruz, Gonzalo
    Perez de la Cruz, Veronica
    CELLS, 2021, 10 (08)
  • [9] Targeting the kynurenine pathway as a novel metabolic treatment for head and neck cancer
    Subramanian, Chitra
    Rajendiran, Thekkelnaycke M.
    Soni, Tanu
    Cohen, Mark S.
    CANCER RESEARCH, 2018, 78 (13)
  • [10] The kynurenine pathway: Towards metabolic equilibrium
    Clarke, Gerard
    Stone, Trevor W.
    Schwarcz, Robert
    NEUROPHARMACOLOGY, 2017, 112 : 235 - 236